Prostate cancer Therapy's hidden heart risk: new study investigates
NCT ID NCT05700903
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 10 men to understand why androgen deprivation therapy (ADT) for prostate cancer can lead to high blood pressure. Researchers checked if problems with the nervous system or kidneys were to blame. The goal is to find ways to prevent heart disease in prostate cancer survivors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGEN DEPRIVATION THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCHealth University of Colorado Hospital
Aurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a few short nights of sleep tip the scales toward high blood pressure?
- A second look: MRI screening may spot hidden prostate cancers
- Chatbot could put blood pressure control in Patients' hands
- Can a 5-Step chat help tame high blood pressure?